About 200 reports

China’s demand for Point of Care Testing (POCT) Devices has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Point Of Care Testing
  • China
  • Industrial Production
  • Labour Force

Abstract: - Global Coagulation/Hemostasis Analyzers Market to Reach $7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Coagulation/Hemostasis Analyzers estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at aCAGR of 8.7% over the period...

  • Diagnostics
  • Laboratory
  • Point Of Care Testing
  • World
  • China
  • United States

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu-Chek Inform II, Freestyle Lite), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2021 - 2028 Point-of-Care Glucose Testing Market Growth & Trends The global point-of-care...

  • Point Of Care Testing
  • APAC
  • North America
  • Diabetes Prevalence

Abstract: - Global Pneumonia Testing Market to Reach $2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pneumonia Testing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 7.9% over the analysis period 2020-2027. Immunodiagnostics,...

  • Point Of Care Testing
  • Infectious Disease
  • Molecular Diagnostics
  • World
  • China
  • United States

The POC data management software market was valued at USD 5916.9 million in 2019, and it is expected to reach a value of USD 11,772.2 million by 2025, registering a CAGR of 12.3% over the forecast period from 2020 to 2025. Point-of-care technologies enable hospitals and clinics to invest more time and money in technologies that help accelerate...

  • Healthcare
  • Point Of Care Testing
  • Diagnostics
  • Software
  • Infectious Disease
  • Laboratory
  • Genetic Testing
  • World
  • APAC
  • Medical Technology Density
  • Health Expenditure

The global lateral flow assay components market is projected to reach USD 420 million by 2027 from USD 339 million in 2022, at a CAGR of 4.3% during the forecast period. The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, the growing demand for point-of-care testing, the increased demand for lateral...

  • Point Of Care Testing
  • World
  • Europe
  • United States
  • North America
  • APAC
  • Health Expenditure
  • Gross Domestic Product

China In-Vitro Diagnostics (IVD) market is predicted to exceed US$ 21 Billion by 2027. China is a large and fast-growing in vitro diagnostics (IVD) market - in fact, only second to the United States in terms of value. Historically, large multinational companies have dominated IVD market in China; today, domestic companies such as Shanghai...

  • In Vitro Diagnostics
  • Point Of Care Testing
  • China
  • Health Expenditure
  • Practising Nurses And Midwives

The global cardiac marker testing market size is projected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2020, at a CAGR of 8.9%. The growth in the cardiac marker testing market is majorly driven by the growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private...

  • Point Of Care Testing
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Disposable Income

The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where...

  • Point Of Care Testing
  • World
  • North America
  • United States
  • India
  • APAC
  • HIV AIDS Prevalence
  • Chronic Disease Prevalence

The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious...

  • Infectious Disease
  • Point Of Care Testing
  • World
  • APAC
  • Europe
  • United States

Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), By End Use (Clinics, Hospital), By Region, And Segment Forecasts, 2020 - 2027 The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding...

  • Point Of Care Testing
  • World
  • North America

The global point of care testing (POCT) market is predicted to exceed US$ 45 Billion by 2026. POC testing appears to be headed for a bigger role in diagnosis and monitoring patient care. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results...

  • Point Of Care Testing
  • World
  • Diabetes Prevalence
  • Cause-Specific Mortality Rate

This study focuses on China’s Point of Care Testing (POCT) Devices industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and...

  • Point Of Care Testing
  • China
  • Employment Costs
  • Employment Income

This study focuses on China’s Point of Care Testing (POCT) Devices industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

  • Point Of Care Testing
  • China
  • Industrial Production
  • Labour Force

KEY FINDINGS The global biochips market is projected to register a CAGR of 13.41% during the forecast period of 2019-2028. Increasing incidences of chronic diseases, rising investments in medical and healthcare research, growth in personalized medicine, developing software and service sectors in proteomics and genomics,...

  • Healthcare
  • Pharmaceutical
  • Molecular Diagnostics
  • Genomics
  • Chronic Disease
  • Point Of Care Testing
  • Biotechnology
  • World

Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19...

  • Diagnostics
  • Point Of Care Testing
  • Artificial Intelligence
  • United States
  • World
  • Europe

the global IVD market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated...

  • In Vitro Diagnostics
  • Point Of Care Testing
  • United States
  • Health Expenditure

Global Ambient Light Sensor Market 2022-2026 The analyst has been monitoring the ambient light sensor market and it is poised to grow by $ 448.91 mn during 2022-2026, progressing at a CAGR of 9.02% during the forecast period. Our report on the ambient light sensor market provides a holistic analysis, market size and forecast,...

  • Marketing Research
  • Semiconductor
  • Automotive
  • Point Of Care Testing
  • World
  • Middle East

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Point Of Care Testing
  • World
  • United States
  • Health Expenditure
  • Mortality Rate

Succeeding in the 2020 PT and APTT Point-of-Care Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers This new 337-page report contains 31 tables, and provides a comprehensive analysis of the PT and APTT testing...

  • Diagnostics
  • Point Of Care Testing
  • World

The global point of care diagnostics market is anticipated to reach US$37.93 billion in 2026, growing at a CAGR of 6.59% during the period spanning 2022-2026. The growth in the market has been driven by factors like rising global healthcare expenditure, rising geriatric population, escalating stress issues, increasing prevalence of chronic...

  • Point Of Care Testing
  • Managed Care
  • World
  • APAC
  • Health Expenditure
  • Diagnostic Revenue

Point of Care Diagnostic Market Size, Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis Point of care testing, is a medical testing that is performed outside of a laboratory setting. The implementation of POC testing is helpful for value-based healthcare...

  • Point Of Care Testing
  • Diagnostics
  • World
  • United States

Report Scope: The current report offers a detailed picture of the point of care diagnostics market. This report highlights the current and future market potential for point of care diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities,...

  • Point Of Care Testing
  • World
  • Diabetes Prevalence

The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers or cardiac markers are endogenous substances which are released in the blood stream when the heart is damaged or stressed. The acute coronary syndrome is...

  • Cardiovascular Disease
  • Biomarker
  • Point Of Care Testing
  • World
  • Asia
  • APAC

The global Helicobacter pylori non-invasive testing market is expected to reach US$ 768.23 Mn in 2027 from US$ 539.70 Mn in 2018. The Helicobacter pylori non-invasive testing market is estimated to grow with a CAGR of 4.1% from 2019-2027. The market is driven by the factors such as, increasing prevalence of Helicobacter pylori bacterial...

  • Laboratory
  • Point Of Care Testing
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

The global point of care testing (POCT) market is expected to surpass US$ 37 Billion by 2025. Point of care testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. POC testing appears to be headed for a bigger role in diagnosis...

  • Point Of Care Testing
  • World
  • Diabetes Prevalence
  • Hospital Number

2022-2026 Point-of-Care (POC) Testing: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers This report provides comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological...

  • Point Of Care Testing

Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have...

  • Point Of Care Testing
  • World
  • Drug Approval
  • Diabetes Prevalence

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these,...

  • In Vitro Diagnostics
  • Research And Development
  • Point Of Care Testing
  • Clinical Chemistry
  • World

China In-Vitro Diagnostics (IVD) market is likely to reach around US$ 17.6 Billion by 2026. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. Historically, large multinational companies have dominated IVD market in China; today, domestic...

  • In Vitro Diagnostics
  • Point Of Care Testing
  • China
  • Health Expenditure
  • Maternal Mortality Rate